Examining Experiences of Federal Offenders on Opioid Agonist Treatment (OAT) During Release from Incarceration in Ontario, Canada: A Post-Release Report

Correctional populations experience high levels of opioid use disorder (OUD) and increased risks for related harms upon the high-risk period of community release and reintegration, including overdose and premature mortality. Opioid agonist therapy (OAT) is an effective treatment for OUD and its provision is associated with a reduction in these and other related risks during the community transition period.Please note that this report is a one page summary. If you wish to have a copy of the full report, please send a request comment via the Open Government Portal or email the OG team: opengovernmentgen-nhq@csc-scc.gc.ca.

Données et ressources

Info additionnelle

Champ Valeur
Dernière modification avril 17, 2026, 20:16 (TU)
Créé le avril 17, 2026, 20:16 (TU)
contact_email opengovernmentgen-nhq@csc-scc.gc.ca
criticality_level ["general_public"]
geographic_scope ["0"]
open_canada_collection publication
open_canada_date_published 2023-05-15 00:00:00
open_canada_keywords {"fr": ["Traitement par agonistes opioïdes", "incarcération", "postlibératoire", "rapport", "délinquants sous responsabilité fédérale", "des expérience", "Ontario"], "en": ["Opioid Agonist treatment", "incarceration", "post-release", "report", "federal offenders", "experiences", "Ontario"]}
open_canada_subject ["law"]
sensitivity_level unrestricted
title_fr Examen des expériences de délinquants sous responsabilité fédérale qui suivent un traitement par agonistes opioïdes (TAO) pendant leur mise en liberté en Ontario, au Canada : rapport postlibératoire
update_frequency as_needed